Tysabri PML Lawsuit

November 10, 2010

TysabriTysabri is a drug prescribed to help patients with multiple sclerosis or Crohn’s disease. Recent reports to the FDA has shown that Tysabri infusions increase the risk of progressive multifocal leukoencephalopathy (PML), an opportunistic viral infection of the brain that usually leads to death or severe disability. Cases of PML have been reported to the FDA in patients taking Tysabri who were recently or concomitantly treated with immunomodulators or immunosuppressants, as well as in patients receiving Tysabri as monotherapy.

Tysabri Side Effects

Tysabri PML is a rare and often fatal infection of the brain. The risk of developing PML increases with the number of Tysabri infusions a patient has received. There is no known cure for progressive multifocal leukoencephalopathy (PML).

Tysabri FDA Warning

The FDA continues to receive reports of progressive multifocal leukoencephalopathy (PML) in patients receiving Tysabri. Tysabri was approved by the FDA for the treatment of relapsing forms of multiple sclerosis (MS) in November 2004 and for moderately to severely active Crohn’s disease in January 2008.

Tysabri and PML Information

Tysabri PML Lawyer

If you or a family member has been diagnosed with PML, or been treated with Tysabri infusions, contact our law firm to speak to a PML lawyer about your legal options. Every attorney at our law firm is dedicated to fighting for the rights of those that have been harmed by dangerous and recalled drugs and medical devices. For over 25 years, Attorney David Willis has been a trial lawyer representing seriously injured clients in product liability and personal injury lawsuits such as defective drug litigation, class action drug lawsuits and medical device recall lawsuits. If Tysabri has harmed you, or a loved one, contact us right now to discuss your potential case in filing a Tysabri PML Lawsuit with an Attorney.

© Willis Law Firm for Drug Attorneys. Replication strictly prohibited without written consent.